Categories
Industry Growth Industry Trends Market Report Market Reports Market Size News

PMR – Endoscopic Mucosal Resection Market to Record Robust CAGR 7.3% During 2025

An endoscopic technique called Endoscopic Mucosal Resection (EMR) is used for the resection of large distal colorectal poylps. EMR was developed for minimally invasive, organ sparing endoscopic removal of benign and early malignant lesions in the GI tract.

EMR is used to treat superficial neoplasms of the gastrointestinal tract. A new research report by Persistence Market Research is based on the analysis of the global endoscopic mucosal resection market and its overview. The report titled ‘Endoscopic Mucosal Resection Market: Global Industry Analysis 2012–2016 and Forecast 2017 – 2025’ includes the major aspects of the market such as the market size, growth rate, pricing analysis and much more.

Report Highlights:

  • Shifting Industry dynamics
  • In-depth market segmentation
  • Historical, current and projected industry size Recent industry trends
  • Key Competition landscape
  • Strategies of key players and product offerings
  • Potential and niche segments/regions exhibiting promising growth
  • A neutral perspective towards market performance

Get Sample Copy of Report @ https://www.persistencemarketresearch.com/samples/13693

Company Profiles 

  • Boston Scientific Corporation
  • Cook Medical Inc
  • Olympus
  • Interscope, Inc.
  • FUJIFILM Holdings Corporation
  • CONMED Corporation
  • STERIS Plc

Get To Know Methodology of Report @ https://www.persistencemarketresearch.com/methodology/13693

According to the report forecast, the global endoscopic mucosal resection market reached a value of over US$ 1,400 Mn in 2017 and this is expected to increase to over US$ 2,500 Mn by the end of 2025. Revenue growth is anticipated to expand at a robust CAGR of 7.3% during the forecast period 2017-2025.

The growth is a result of new technological advancements in the global endoscopic mucosal resection market and companies are ready to make full use of this by launching new products in the market.

Global Endoscopic Mucosal Resection Market: Dynamics

The global endoscopic mucosal resection market has a major support of the macro factors like increase in the spending on healthcare sector in various regions by the local governments. This has led to an overall improvement in the technology used by the healthcare industry.

It has helped in increasing the number of endoscopic mucosal resection procedures worldwide. The market has also observed collaborations between the manufacturers. Original equipment manufacturers and third party service vendors focus on the collaboration and partnership activities in some regions to provide sales and after sales services effectively.

This boosts the brand image of endoscope devices and ultimately helps the growth of the global endoscopic mucosal resection market.

However, the global endoscopic mucosal resection market may face challenges in its growth due to stringent rules and regulations pertaining to the launch of new products in the market. Also, inadequate reimbursements of claims limits the willingness of people to spend on costly medical procedures like endoscopic mucosal resection.

Access Full Report @ https://www.persistencemarketresearch.com/checkout/13693

Segmental Highlights from the Research Report

On the basis of region, Asia Pacific is expected to dominate the global market with the fastest growth rate of 7.9% during the forecast period. Another attractive region in the global endoscopic mucosal resection market is North America that is anticipated to hold the maximum market size by the end of 2025.

On the basis of technology, suck-and-cut technique is the most lucrative segment with a high CAGR, whereas the lift-and-cut technique leads with a higher market size during the forecast period.

On the basis of indication duodenal cancer and esophageal cancer are both attractive segments according to the analysis.

On the basis of end user, hospitals hold the maximum market size with an expected value of over US$ 1,400 Mn by the end of 2025.

Categories
Industry Growth Industry Trends Market Report Market Reports Market Size News

PMR – Alcohol Breathalyzer Drug Testing Equipment Market to Grow at Stellar CAGR 7.8% During the Forecast Period 2021

The latest market report published by Persistence Market Research is titled ‘Global Market Study-Alcohol Breathalyzer and Drug Testing Equipment – Asia Pacific to Witness Maximum Growth by 2026’. According to this report, the global alcohol breathalyzer and drug testing equipment market will expand at a CAGR of 6.9% during the forecast period, 2017–2026. The global revenues are expected to take a leap from around US$ 7.30 Bn (2017) to over US$ 13.30 Bn by the end of 2026.

Market Taxonomy: Quick Overview

This market is segmented on the basis of equipment, application, end user, and region. On the basis of equipment, the market has been sub-segmented into semi-conductor based breathalyzer, infrared (IR) based breathalyzer, fuel cell based breathalyzer, immunoassay analyzers, chromatography instruments, oral fluid testing devices, urine testing devices, and hair testing devices.

Report Highlights:

  • Shifting Industry dynamics
  • In-depth market segmentation
  • Historical, current and projected industry size Recent industry trends
  • Key Competition landscape
  • Strategies of key players and product offerings
  • Potential and niche segments/regions exhibiting promising growth
  • A neutral perspective towards market performance

Get Sample Copy of Report @ https://www.persistencemarketresearch.com/samples/3377

Companies Profiles

  • Drägerwerk AG & Co. KGaA
  • Lion Laboratories Limited
  • Lifeloc Technologies Inc.
  • Intoximeters
  • Andatech Pty. Ltd.
  • BACtrack
  • Quest Products, Inc.
  • Alere (Abbott.)
  • C4 Development Ltd (Alcovisor)

Get To Know Methodology of Report @ https://www.persistencemarketresearch.com/methodology/3377

On the basis of application, the market has been segmented into drugs detection and alcohol detection. On the basis of end user, the market has been segmented into federal departments, hospitals, rehabilitation centers, and private sectors.

By equipment, IR based breathalyzer is expected to remain the largest segment, registering the highest CAGR of 7.2% during the forecast period. Accuracy of such evidential breath testing (EBT) devices is very high, as a result they are being widely used by federal departments and hospitals.  Fuel cell based breathalyzer are expected to register a CAGR of 7.3% during the forecast period.

These type of portable devices offer extremely high accuracy concerning blood alcohol content (BAC) and provide instant results. Moreover, such devices require fewer recalibrations as compared to semiconductor-based alcohol breathalyzers. These factors are generating significant demand for fuel cell based breathalyzers globally.

On the basis of region, the market has been segmented into North America, Latin America, Europe, Asia Pacific and the Middle East and Africa. North America is expected to dominate the market, with a maximum share by the end of 2018.

North America, Europe, and Asia Pacific are expected to collectively contribute over 94.0% revenue to the total global alcohol breathalyzer and drug testing equipment market. In terms of value, Asia Pacific is estimated to be the fastest growing market, registering a CAGR of 7.9% during the forecast period.

Access Full Report @ https://www.persistencemarketresearch.com/checkout/3377

Soaring Alcohol Consumption & Drug Abuse Cases to Fuel Market Growth

Increasing cases of alcohol and drugs abuse are a major factor driving growth of the global alcohol breathalyzer and drugs testing equipment market. Other trends driving growth include single technology devices for alcohol and drugs testing and increasing market share of personal breathalyzers.

In addition, stringent government regulations, emergence of low cost breathalyzers and growing distribution networks in developing countries are projected to result in increased demand. This in turn is expected to bolster alcohol breathalyzer and drugs testing equipment market growth during the forecast period (2017–2026).

High pricing issues and fewer opportunities for new market players in the developed regions are the key factors hampering the growth of this market. Major players dominate the market in developed regions, whereas local players in domestic regions offer products at prices cheaper by 20%–30% compared to established brands in North America and Europe. This factor has been identified to be a challenge to development and growth of the overall alcohol breathalyzer and drugs testing equipment market.

Key market players covered in this report include Drägerwerk AG & Co. KGaA, Lion Laboratories Limited, Lifeloc Technologies Inc., Intoximeters, Andatech Pty. Ltd., BACtrack, Quest Products, Inc., Alere (Abbott.), and C4 Development Ltd (Alcovisor).

These companies are primarily focused on enhancing their product portfolios through research and development, and introduction of innovative and cost-effective medical devices in order to gain market share and strengthen their position in the global market.

The global alcohol breathalyzer and drug testing equipment market is segmented as follows:

By Equipment

  • Breathalyzer (Semiconductor)
  • Intoxilyzer (IR)
  • Alcosensor (Fuel Cells)
  • Immuno Assay Analyzers
  • Chromatographic Instruments
  • Oral Fluid Testing Devices (Saliva)
  • Urine Testing Devices (Kits, Cassets, cups and Dips)
  • Hair Testing Devices (Kits)

By Application

  • Alcohol Detection
  • Drugs Detection

By End-users

  • Federal Departments
  • Hospitals
  • Rehabilitation Centers
  • Private Sectors

By Region

  • North America
  • Latin America
  • Europe
  • Asia Pacific
  • Middle East & Africa (MEA)
Categories
Industry Growth Industry Trends Market Report Market Reports Market Size News

PMR – Osteoarthritis Market to Register CAGR 4.8% Increase in Revenue by 2025 End

Persistence Market Research (PMR) has published a new research report on the osteoarthritis treatment market titled “Osteoarthritis Treatment Market: Global Industry Analysis (2012-2016) and Forecast (2017-2025).” An alarming rise in the number of osteoarthritis cases is the result of a growing geriatric population worldwide. In order to cater to the needs of the rapidly increasing geriatric population as well as the female population – given that osteoarthritis prevails mostly among these groups – the manufacturers of osteoarthritis drugs are focusing on research and development to be able to develop better and reliable drugs.

As this disease is not treatable, the market is an ever growing one. In this run, the leading companies are also collaborating with other big companies in order to use their formulas and production equipment.

Report Highlights:

  • Shifting Industry dynamics
  • In-depth market segmentation
  • Historical, current and projected industry size Recent industry trends
  • Key Competition landscape
  • Strategies of key players and product offerings
  • Potential and niche segments/regions exhibiting promising growth
  • A neutral perspective towards market performance

Get Sample Copy of Report @ https://www.persistencemarketresearch.com/samples/4458

Company Profiles

  • Pfizer Inc.
  • Johnson & Johnson Services, Inc.
  • Novartis AG
  • GlaxoSmithKline plc.
  • Zimmer Biomet Holdings, Inc.
  • Stryker Corporation
  • Abbott Laboratories

Get To Know Methodology of Report @ https://www.persistencemarketresearch.com/methodology/4458

For instance, in September 2016, Pfizer Inc. completed the acquisition of Medivation, Inc., a biopharmaceutical company focused on the development and commercialization of medically innovative therapies to treat serious diseases that have limited treatment options.

In this regard, the company also acquired the commercialization and development rights of the late stage small molecules anti-infective business, mainly outside the U.S. from AstraZeneca. Other companies operating in the market are Johnson & Johnson Services, Inc., Novartis AG, GlaxoSmithKline plc. Abbott Laboratories, and Zimmer Biomet Holdings, Inc., among others.

According to the report, the global osteoarthritis treatment market is expected to register a CAGR of 4.8% from 2017 to 2025. In 2017, the market was valued at US$ 7,969.7 Mn and is expected to rise to a valuation of US$ 11,618.6 Mn by the end of 2025.

Growing Geriatric Population and Rising Prevalence of Disease to Trigger Adoption

The prevalence of osteoarthritis is increasing across the globe and it is the major cause of disability, especially among the ageing population. Women are more likely to be affected than men and the prevalence rate progresses with age. Increasing awareness regarding the risk factors associated with osteoarthritis (such as obesity) among the general population due to government action plans to control the disease is expected to boost the growth of the osteoarthritis treatment market.

However, improvement in healthcare policies in various countries such as the U.S. has resulted in enhanced affordability for various diagnostic and treatment services, which in turn has increased the life expectancy of people. Other dynamics such as the availability of alternative medicines are expected to boost the growth of the market.

Access Full Report @ https://www.persistencemarketresearch.com/checkout/4458

Non-availability of Permanent Cure for Osteoarthritis to Restrict Market Growth

Presently, there is no cure of osteoarthritis but the treatment is aimed to manage the symptoms. Aspects such as lack of awareness regarding risk factors and symptoms of osteoarthritis is expected to restrain the growth of the osteoarthritis treatment market.

There is no simple diagnosis available for osteoarthritis. Diagnosis is based on a variable combination of patient reported symptoms and imaging of the joint. Mostly x-ray is used to diagnose osteoarthritis, but it often does not correlate with other symptoms of osteoarthritis including joint pain.

Categories
Industry Growth Industry Trends Market Report Market Reports Market Size News

PMR – Remote Patient Monitoring Device Market to Register a Growth Rate of CAGR 6.7% During the Forecast Period 2024

Remote patient monitoring is gaining popularity owing to the increase in chronic diseases and aging population. In the traditional healthcare setting all the data collected is lost as soon as the patient leaves the hospital and it is only found when a patient visits again.

However, remote patient monitoring device helps in collecting the data and share it even from a remote location outside hospital or clinic. The concept of telemedicine is also gaining momentum. It allows remote diagnosis and treatment of patients using a telecommunication device, this reduces cost substantially and offers care with comfort.

Report Highlights:

  • Shifting Industry dynamics
  • In-depth market segmentation
  • Historical, current and projected industry size Recent industry trends
  • Key Competition landscape
  • Strategies of key players and product offerings
  • Potential and niche segments/regions exhibiting promising growth
  • A neutral perspective towards market performance

Get Sample Copy of Report @ https://www.persistencemarketresearch.com/samples/3287 

Company Profiles

  • Boston Scientific Corporation
  • Koninklijke Philips N.V.
  • Abbott Laboratories
  • Nihon Kohden Corporation
  • F. Hoffmann-La Roche Ltd.
  • LifeWatch AG
  • Medtronic
  • St. Jude Medical

Get To Know Methodology of Report @ https://www.persistencemarketresearch.com/methodology/3287

The manufacturers of remote patient monitoring devices are also focusing on research and development activities and increasingly investing in the same. This is being done to improve the remote patient monitoring device currently offered and also decrease the high cost of devices.

Companies are also looking forward to come-up with a mobile application for remote patient monitoring, thereby, eliminating the need to spend on costly hardware. Manufacturers are developing cardiovascular and respiratory devices with increasing people suffering from various heart and breathing diseases. Hence, portable device monitoring heart rate and blood pressure. Sensor-based devices monitoring oxygen levels and to monitor medication usage are also being provided.

As per the report published by Persistence Market Research, the global remote patient monitoring device is likely to witness a significant growth during the forecast period 2017-2024. The global remote patient monitoring devices market is projected to surpass US$ 1000 Million revenue by the end of 2024.

Cardiac Monitors to Witness the Highest Sales in the Global Market   

Based on the product type, cardiac monitors are likely to witness the highest sales during 2017-2024. In terms of value, cardiac monitors are estimated to reach close to US$ 800 Million by 2024 end.

On the basis of indication, cardiac arrhythmia is expected to see a significant growth throughout the forecast period 2017-2024. Cardiac arrhythmia is projected to exceed US$ 300 Million revenue by the end of the forecast period. Meanwhile, ischemic diseases are also likely to see impressive growth in the global market for remote patient monitoring devices.

By the end user, hospitals followed by homecare setting are likely to experience a robust growth during 2017-2024. By the end of 2024, hospitals as the end users are projected to bring in nearly US$ 700 Million revenue.

Access Full Report @ https://www.persistencemarketresearch.com/checkout/3287

North America to Lead the Global Remote Patient Monitoring Devices Market

North America is expected to remain dominant in the global market for remote patient monitoring devices during 2017-2024. By 2024 end, North America is likely to surpass US$ 500 Million in terms of revenue. The U.S. is one of the largest countries in the region for remote patient monitoring devices.

Technological advancements and the growing need for comfort is driving the demand for home-based monitoring devices. According to the report from American Heart Association, more than 80 million Americans have high blood pressure and more than 90 million Americans carry a diagnosis of cardiovascular diseases. Hence, the demand for remote patient monitoring devices is gaining traction in the region.

Categories
Industry Growth Industry Trends Market Report Market Reports Market Size News

PMR – Sales of Hip Replacement Market to Grow at Robust CAGR 4.1% During 2024

A newly compiled business and commerce study done at the headquarters of Persistence Market Research (PMR) notifies that the competition in the global hip replacement market is stiff. And, the sheer profitability of the healthcare domain will continue to attract newer players in the near future, which will further fragment the vendor landscape.

That being said, the analyst of the report has detected that a few players do hold a moderate position of strength over the rest of the competition, having established themselves over a number of years across regions as well as leading the innovation.

Report Highlights:

  • Shifting Industry dynamics
  • In-depth market segmentation
  • Historical, current and projected industry size Recent industry trends
  • Key Competition landscape
  • Strategies of key players and product offerings
  • Potential and niche segments/regions exhibiting promising growth
  • A neutral perspective towards market performance

Get Sample Copy of Report @ https://www.persistencemarketresearch.com/samples/12037

Company Profiles

  • Depuy Synthes (J&J)
  • Microport Scientific Corporation
  • Zimmer Biomet
  • Exactech Inc.
  • DJO Global Inc.
  • Stryker Corporation
  • B Braun Melsungen
  • Smith & Nephew

Get To Know Methodology of Report @ https://www.persistencemarketresearch.com/methodology/12037

Geographical Presence Determining Market Leader

For instance, Zimmer Biomet Holdings Inc. operates in more than 25 nations and offers a wide-range of products that are used for joint reconstruction and minimally invasive surgeries. The company is maintaining a good relationship with major group purchasing organizations (GPO) and continuously collaborates with healthcare professionals in developed regions. Smith & Nephew, another leading name in medical device manufacturing, has a global presence and has gone through various acquisitions and partnerships to enhance its portfolio.

Stryker Corporation, DJO Global, Depuy Synthes from Johnson and Johnson, and B. Braun Melsungen AG are some of the other prominent players in the global hip replacement market.

The analyst of the PMR report has projected the demand in the global hip replacement market to expand at a CAGR of 4.2% during the forecast period of 2017 to 2024. In terms of revenue, the analyst has estimated that there will be opportunities worth US$9,128.5 mn by the end of 2024 in the market for hip reconstruction, substantially more than the market’s evaluated valuation of 6,830.5 mn in 2017.

Based on product type, the report segments the hip replacement market into revision hip implants, partial hip replacement implant, hip resurfacing, and total hip replacement implant.

Access Full Report @ https://www.persistencemarketresearch.com/checkout/12037

On the basis of component type, the market has been bifurcated into hip stem systems, revision accessories and components, and acetabular cup systems. The analyst has also categorized this market in terms of end user, into ambulatory surgery centers (ASCs), clinics, and hospitals. Geographically, the developed region of North America has been identified as the most profitable region, followed by Europe and then vastly populated Asia Pacific.

Prevalence of Obesity and Arthritis to Sustain Strong Demand

Radically rising percentage of geriatrics in the world’s population is the primary driver of the hip replacement market. People aged over 60 years, as well as those who suffer from obesity and arthritis, are highly prone to hip disorders and are expected to drive the demand over the course of next seven years.

In addition to that, advancements in minimally invasive surgeries coupled with 3D printing has led to growth of the global hip replacement market. Medical device manufacturers are largely focusing on emerging economies due to large patient base and growing demand for hip replacement surgeries.

Moreover, rising number of revision surgeries coupled with growing capabilities of advanced biomaterial-based implants is further supporting market growth. Government initiatives and subsidies provide advanced healthcare to their aging population, increasing incidence of trauma or accidental injuries, increasing manufacturing of short stems in total hip arthroplasty, and introduction of custom made implant products are some of the other drivers of the hip replacement market.

On the other hand, substantial cost of the products and pertaining surgeries is holding the market from gaining new consumers in underdeveloped regions. Moreover, stringent regulations from the FDA for all metal hip implant products is reflecting negatively over the market for hip reconstruction.

Categories
Industry Growth Industry Trends Market Report Market Reports Market Size News

PMR – Western Blotting Market to Register CAGR 5.4% Growth in Revenue During the Forecast Period 2021

The rising incidence of HIV, growing applications of western blotting technique in the field of proteomics and the growing expenditure on research and development by various pharmaceutical and biotechnology companies are some of the major factors stimulating the growth of the global western blotting market during the forecast period, 2017-2021.

These are some of the findings of the latest comprehensive report which has been released by Persistence Market Research titled as ‘Western Blotting Market: Global Industry Analysis and Forecast 2017-2021’. This report explores the market dynamics affecting the expansion of the global western blotting market in the form of drivers, restraints, opportunities and trends, which are comprehensively studied in this latest report.

Report Highlights:

  • Shifting Industry dynamics
  • In-depth market segmentation
  • Historical, current and projected industry size Recent industry trends
  • Key Competition landscape
  • Strategies of key players and product offerings
  • Potential and niche segments/regions exhibiting promising growth
  • A neutral perspective towards market performance

Get Sample Copy of Report @ https://www.persistencemarketresearch.com/samples/3044

Company Profiles :

  • Thermo Fisher Scientific, Inc.
  • GE Healthcare.
  • Hoffmann-La Roche Ltd.
  • Danaher Corporation (Lumigen, Inc.)
  • EMD Millipore Corporation.
  • Bio-Rad Laboratories, Inc.
  • PerkinElmer Inc., LI-COR, Inc.
  • Bio-Techne Corporation (ProteinSimple Inc.)
  • Advansta, Inc.

Get To Know Methodology of Report @ https://www.persistencemarketresearch.com/methodology/3044

As per the forecast, the global western blotting market was valued at US$ 576.4 Mn in 2017 end and is slated to reach a valuation of US$ 725 Mn in 2021 end, reflecting a CAGR of 5.9% during the period of forecast 2017-2021.

Global Western Blotting Market: Market Dynamics

According to the data provided by UNAIDS, there were approximately 36.7 million people across the global living with HIV/AIDS. Western blot testing method is preferred in detection on HIV as it is greatly accurate in finding HIV antibodies in the blood of patients as compared with other testing techniques like ELISA. The diagnosis of HIV is dependent on the detection of the HIV antibody in blood, by the incorporation of HIV antigens. This kind of antigen-antibody assay is helpful in window period of HIV.

Hence, western blotting testing technique is preferred in the detection of anti-HIV antibody in blood serum sample. In addition, there is an increasing amount of investments in R&D sector in the western blotting market for system automation, antibodies, regent kits and buffers.

Such kind of investments are likely to boost the growth of the global western blotting market. However, the emergence of alternative techniques like the alpha technique, which is much simpler than the western blotting technique may restrain the growth of the global western blotting market.

Access Full Report @ https://www.persistencemarketresearch.com/checkout/3044

Global Western Blotting Market: Segmentation and Forecast

The global western blotting market is segmented on the basis of product, end-use, application and region.

On the basis of product, the reagent kits dominated the market. The reagent kits segment was valued at US$ 350.5 Mn in 2017 end. The transfer membranes segment was valued at US$ 62.3 Mn in 2017 end. Innovative reagents are being used for clear visibility and imaging and to reduce the duration of test process are some of the key factors boosting the growth of the reagents kits segment in the western blotting market.

On the basis of application, the scientific research segment was valued at US$ 215.7 Mn in 2017 end. The food and beverage segment was valued at US$ 60.9 Mn in 2017 end. Scientific research segment is projected to reach US$ 277.0 Mn by 2021, creating a total incremental opportunity of US$ 88.3 Mn over the forecast period.

On the basis of end-use, the diagnostic laboratories segment was valued at US$ 145.7 Mn in 2017 end. Need for continuous monitoring of patients suffering from HIV is expected to fuel demand for western blotting tests over the forecast period.

On the basis of region, the Asia Pacific western blotting market was valued at US$ 129.2 Mn in 2017 end. There is a high potential for the growth of western blotting market in the region of Asia Pacific.

Categories
Industry Growth Industry Trends Market Report Market Reports Market Size News

PMR – Hair Transplant Services Market to Witness CAGR 6.7% Growth in Revenue During the Period 2025

People from every age group are facing hair fall related problems. This has created a demand for hair transplant and treatment across the globe which in turn is expected to spur the growth of the market for hair transplant services. People are more inclined towards hair transplant due to availability of new hair transplant services.

The global market for hair transplant services includes three major types of procedures, i.e. Follicular Unit Strip Surgery (FUSS), Follicular Unit Extraction (FUE) and Scalp Reduction.

Report Highlights:

  • Shifting Industry dynamics
  • In-depth market segmentation
  • Historical, current and projected industry size Recent industry trends
  • Key Competition landscape
  • Strategies of key players and product offerings
  • Potential and niche segments/regions exhibiting promising growth
  • A neutral perspective towards market performance

Get Sample Copy of Report @ https://www.persistencemarketresearch.com/samples/11602

Company Profiles

  • Bernstein Medical, P.C.
  • Bosley Inc.
  • Medicamat
  • Hair Transplants of Florida
  • The Ac?badem Hospitals Group
  • Limmer Hair Transplant Center
  • getFUE Hair Clinics Ltd
  • Hair Transplant Center Turkey
  • The Hairline Clinic

Get To Know Methodology of Report @ https://www.persistencemarketresearch.com/methodology/11602

A new research report covers the complete scenario of the global hair transplant services market. Persistence Market Research in its new report titled ‘Hair Transplant Services Market: Global Industry Analysis (2012 – 2016) and Forecast (2017 – 2025)’ has covered a brief about the global hair transplant services market’s value, growth rate, trends, opportunities and drivers.

According to the research study, the global hair transplant services market is expected to reach a value of over US$ 9,100 Mn by the end of 2025, growing at a CAGR of 6.7% during the forecast period. The demand for hair transplant services is mainly driven by the increase in disposable income with the people and also an increase in the stress level among people which is resulting in their excessive hair loss.

Increasing incidences of various dermatologic disorders and rise in number of reported side effects such as hair loss associated with chemotherapy in cancer patients are few factors expected to contribute significantly to growing demand for effective hair loss products.

With growing demand, manufacturers are focusing on expanding their hair treatment and scalp treatment product lines in order to cater to the increasing needs of consumers for efficient hair loss treatments.

Access Full Report @ https://www.persistencemarketresearch.com/checkout/11602

Global Hair Transplant Services Market: Segmental Insights

Based on procedures, follicular unit strip surgery leads the market with a higher market share and growth rate. Follicular unit extraction segment stands at the second position leaving behind scalp reduction with the lowest market size during the forecast period.

On the basis of end users, hospitals are expected to showcase maximum demand for hair transplant services. Hospitals segment is expected to reach a market value of over US$ 4,200 Mn by the end of 2025, growing at a value CAGR of 7.2% during the forecast period. Specialized clinics segment is also expected to be an attractive segment for hair transplant services.

Among the regional segments, North America dominates the market with an estimated market value of over US$ 3,800 Mn by the end of 2025, growing at a CAGR 7.2% during the forecast period. APAC is also expected to be an attractive segment, growing at a significant CAGR during the forecast period.

Categories
Industry Growth Industry Trends Market Report Market Reports Market Size News

PMR – Sales Revenue in the Microbiome Therapeutic Market to Witness Growth at Robust CAGR 62.9% During 2025

According to the latest market report published by Persistence Market Research, titled ‘Microbiome Therapeutics Market Potential: Global Pipeline Analysis and Assessment 2018 – 2025’, the global microbiome therapeutics market is expected to exhibit an exponential CAGR of 62.9% during the forecast period 2018–2025.

Persistence Market Research estimates that the global market for microbiome therapeutics is expected to be valued at US$ 10.1 Mn in 2018 and is expected to reach US$ 897.3 Mn by 2025 end. Need for reliable, precise and fast treatment options for certain diseases, such as C. difficile infection (CDI), phenylketonuria, hepatic encephalopathy and multidrug resistant urinary tract infection creates a huge potential for the growth of the microbiome therapeutics market.

Report Highlights:

  • Shifting Industry dynamics
  • In-depth market segmentation
  • Historical, current and projected industry size Recent industry trends
  • Key Competition landscape
  • Strategies of key players and product offerings
  • Potential and niche segments/regions exhibiting promising growth
  • A neutral perspective towards market performance

Get Sample Copy of Report @ https://www.persistencemarketresearch.com/samples/7990

Company Profiles

  • Microbiome Therapeutics Inc.
  • SERES Therapeutics Inc.
  • LNC Therapeutics Inc.
  • Vedanta Biosciences Inc.
  • Enterome SA
  • Ferring B.V.
  • ViThera Pharmaceuticals Inc.
  • Second Genome Therapeutics
  • Rebiotix
  • Synlogic Inc.
  • 4D Pharma Plc.
  • Ritter Pharmaceuticals
  • AvidBiotics
  • Osel Inc.
  • OxThera AB
  • Evelo Biosciences
  • AOBiome LLC
  • Immuron Ltd.

Breakthrough therapy designation and orphan drug approvals for microbiome therapeutics is expected to accelerate the launch of developmental drugs in the microbiome therapeutics market. A huge pipeline with over 120 candidates in different stages of development further creates the platform for potential growth of the microbiome therapeutics market.

More Than 120 Drugs Are in the Pipeline in the Global Microbiome Therapeutics Market

At present there are no marketed microbiome therapeutics in the global market; however, the first drug is expected to be launched in 2018. The global market is dominated by over 25 companies with more than 120 drugs in the pipeline at different stages of development.

However, over 60% of these drugs are in the discovery or preclinical phase, where there is high uncertainty surrounding the success of these molecules to reach the clinical phase and being launched as a new drug molecule. Majority of the pipeline drugs are being developed for gastrointestinal disorders and contribute approximately 28.7% of the total pipeline products.

Research and development in the microbiome industry is prominently dependent on government funding and research grants. Formation of policies and provision of subsidy by various governments encourages research and development activities across various segments of the research including discovery and clinical research.

Government initiatives in funding microbiome research is the preliminary factor driving revenue growth of global microbiome therapeutics market. For instance, the U.S. government had allocated US$ 1.6 Bn for microbiome R&D programs in 2016 & 2017.

Access Full Report @ https://www.persistencemarketresearch.com/checkout/7990

Global Microbiome Therapeutics Market: Segmentation and Forecast

The market is segmented based on indication and region. On the basis of indication, the market has been segmented into type 2 diabetes, obesity, C. difficile infection and primary hyperoxyurea. C. difficile infection indication segment is expected to contribute the highest market share of over 34% by 2025 end. More number of product approvals for CDI is attributed to a high share of the C. difficile infection segment in the global market.

Human gut is home to over 100 Tn bacteria, containing thousands of different species. Long-term exposure to antibiotics causes dysbiosis in gut microbial composition, which leads to a variety of gastrointestinal disorders including CDI, ulcerative colitis, IBD, bacterial infection and even antibiotic associated diarrhea.

Microbiome therapeutics however, present an excellent option for the treatment of CDI and other gastrointestinal disorders, as they are designed to naturally cure dysbiosis and bring the microbiome system back to normal functioning.

Global Microbiome Therapeutics Market: Regional Forecast

On the basis of region, the market has been segmented into the U.S., Europe, Japan and Rest of the World (RoW). U.S. is estimated to contribute the highest share of over 44% by 2025 end, due to early launch of microbiome therapeutics and high penetration compared to other markets.

The market in Japan is expected to witness delayed growth due to the complex regulatory pathways for new biological drugs. The microbiome therapeutics market in the rest of the world is expected to show gradual acceptance of “bug medicine”, Canada being the most lucrative among the rest of the world countries.

Majority of the players in the microbiome therapeutics market are engaged in partnerships and collaborations with established pharmaceutical companies and academic institutes. Small start-up and clinical stage microbiome companies are capitalizing on venture financing to establish microbiome based novel therapeutics in the global market.

Despite of decrease in the overall venture capital investments, the microbiome industry has witnessed high VC investments in 2016, and raised approximately to US$ 336 Mn in 2016. Partnerships and research collaborations are another prominent trends identified in global microbiome therapeutics market.

Categories
Industry Growth Industry Trends Market Report Market Reports Market Size News

PMR – Stair Lifts Market to Register CAGR 7% Growth in Value Share During 2024

Stair lifts are a mechanical setup that aims to help disabled people. This is a chair or platform that is motorized to travel along the rail or track guided along the stairway. A new research based on these lifts by Persistence Market Research is titled ‘Stair Lifts Market: Global Industry Analysis 2012 –2016 and Forecast 2017 – 2025’. This comprehensive research is intended to guide people with useful insights on this market.

The stair lifts market study involves assessment of global market opportunities by representing annual sales volume (units) and value (US$ Mn) of various types of stair lifts installed in residential and commercial or public spaces. The report indicates that the global stair lifts market is expected to reach a market value of over US$ 1,600 Mn by the end of 2025. The market is projected to register a robust CAGR of 6.5% during the forecast period.

Report Highlights:

  • Shifting Industry dynamics
  • In-depth market segmentation
  • Historical, current and projected industry size Recent industry trends
  • Key Competition landscape
  • Strategies of key players and product offerings
  • Potential and niche segments/regions exhibiting promising growth
  • A neutral perspective towards market performance

Get Sample Copy of Report @ https://www.persistencemarketresearch.com/samples/5621

Company Profiles

  • Acorn Stairlifts Inc.
  • Stannah International
  • Savaria Corp.
  • Handicare Group AB
  • Lehner Lifttechnik GmbH
  • Otolift Stairlifts Ltd.
  • Harmar Mobility LLC
  • Prism U.K. Medical Limited
  • Bruno Independent Living Aids, Inc.
  • Platinum Stair Lifts Ltd.
  • HIRO LIFT (Hillenkötter + Ronsieck
  • Kumalift Co., Ltd.
  • SUGIYASU Co., Ltd.
  • Symax Lift (China) Co, Ltd.
  • Qingdao Sinofirst Machinery Co., L
  • Taamal Seed Electra Group
  • Gruppo Millepiani S.p.a

Get To Know Methodology of Report @ https://www.persistencemarketresearch.com/methodology/5621

Over the last decade, stair lifts have witnessed a substantial surge in demand in the U.S and Japan market. This demand is mainly driven by a growing geriatric population. Market players lay emphasis on increasing their product offerings and providing innovative products to achieve competitive edge, specifically over other local players.

Global Stair Lifts Market: Segmental Analysis

On the basis of region, North America leads the global market with over US$ 420 Mn market revenue expected by the end of 2025, growing at a CAGR of 7.3% during the forecast period. Europe is also expected to emerge as an attractive region during the forecast period.

In terms of rail type, curved stair lifts is projected to have the largest market share by the end of 2025, whereas straight stair lifts is expected to be the fastest growing segment with a growth rate of 7.5% during the forecast period.

Access Full Report @ https://www.persistencemarketresearch.com/checkout/5621

Based on install location, the residential spaces segment is ahead of commercial spaces with a higher market share, but the commercial spaces segment is projected to witness a higher growth rate during the forecast period.

On the basis of power source, the direct current segment dominates the global stair lifts market with a projected market value of over US$ 1,300 Mn by the end of 2025, growing at a CAGR of 7.2% by the end of forecast period.

Categories
Industry Growth Industry Trends Market Report Market Reports Market Size News

PMR – Single Lead Ecg Machines Market Revenue to Rise by CAGR 9.9% Owing to Increasing End-use Adoption

Understanding various facets of the global single-lead ECG monitors market, Persistence Market Research has come up with an analytical research publication titled “Single-Lead ECG Monitors Market: Global Industry Analysis (2012-2016) and Forecast (2017-2025)”.

The comprehensive single-lead ECG monitors market research report focuses on various trends, developments, opportunities, restraints, drivers and challenges impacting the growth of the global single-lead ECG monitors market.

Report Highlights:

  • Shifting Industry dynamics
  • In-depth market segmentation
  • Historical, current and projected industry size Recent industry trends
  • Key Competition landscape
  • Strategies of key players and product offerings
  • Potential and niche segments/regions exhibiting promising growth
  • A neutral perspective towards market performance

Get Sample Copy of Report @ https://www.persistencemarketresearch.com/samples/3784

Company Profiles

  • DailyCare BioMedical Inc.
  • Shenzhen Creative Industry Co. Ltd.
  • AliveCor Inc.
  • Medtronic Plc.
  • LifeWatch AG
  • OMRON Healthcare
  • Lohman Technologies (Cardiac Advancement
  • iRhythm Technologies Ltd.
  • Reka Health Pte Ltd.
  • Beijing Choice Electronic Tech Co., Ltd
  • DIMETEK Digital Medical Technologies, L
  • Cardiac Design Labs
  • Thermo Fisher Scientific, Inc.
  • Lyfas, Acculi Labs Pvt. Ltd. India
  • Vital Connect Inc.
  • Qardio, Inc.
  • ProtoCentral
  • NUUBO Smart Solutions Technologies, SL

Get To Know Methodology of Report @ https://www.persistencemarketresearch.com/methodology/3784

These factors vary in magnitude in different regions for which a detailed analysis is covered in this research report. Along with this, a detailed competition assessment and forecasts for a period of eight years from 2017-2025 are elaborated with respect to each segment and sub-segment of the global single-lead ECG monitors market.

Global Single-Lead ECG Monitors Market: Insights on Market Segments

The global market for single-lead ECG monitors is segmented on the basis of product type, application, end user and region.

By product type, recording based single-lead ECG monitor segment is estimated to largely contribute to the valuation of the global market. The real-time single-lead ECG monitor segment is projected to grow at a comparatively high CAGR of 12.9% during the forecast period

Application wise, there is a higher demand for single-lead ECG monitors in atrial fibrillation indication. The atrial fibrillation application segment is also estimated to be the largest and expected to be the most lucrative in the coming year

By region, use of single-lead ECG monitors in North America, especially in the U.S, is increasing at a high scale due to increasing prevalence of cardiovascular and other chronic diseases. Moreover, Asia Pacific region is expected to show higher adoption of single-lead ECG monitors, thus making this region as a potential growth propeller portraying huge opportunities for manufacturers of single-lead ECG monitors

Access Full Report @ https://www.persistencemarketresearch.com/checkout/3784

By end user, home care settings segment is expected to show significant market attractiveness with respect to use of single-lead ECGs. However, hospital facilities segment is the largest with a high market valuation of about US$ 186 Mn in 2017

Global Single-Lead ECG Monitors Market: Market Forecast Analysis

The global single-lead ECG monitors market is expected to witness stellar growth in the coming years. The global market for single-lead ECG monitors was valued at around US$ 344 Mn in 2017 and is estimated to reach a valuation of more than US$ 730 Mn by the end of 2025. The global market for single-lead ECG monitors is projected to grow at a value CAGR of 9.9% throughout the period of forecast (2017-2025).